Shin Enosawa, DDS, PhD
From 2011 to 2016, worked as Project Manager for the Highway Project, "Clinical research on human embryonic stem (ES) cell formulations for the treatment of congenital metabolic disorders giving rise to severe hyperammonemia", a research fund awarded to Dr. Akihiro Umezawa.
Akihiro Umezawa, MD, DMSc
From 2012 to 2017, also worked as Deputy Director of the Review Center for Regenerative Medicine of the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan and from 2017 to 2019 as Special Assistant to the President of the PMDA.
When | Session | Talk Title | Room |
---|---|---|---|
Fri-27 14:00 - 15:40 |
Concurrent Session — Translation of regenerative medicine technologies to the clinic (CTRMS) | Stem cells clinical trial in Japan and brief historical perspective and current status | Indigo D |